• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Sunday 06/24/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Zestra

  • 2:45 PM

    Company in a Strong Cash Position for Product Launches and Expedited Growth SAN DIEGO, CA– INNV, (Marketwired – Aug 1, 2016) – Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company) www.innovuspharma.com (OTCQB: INNV), a company focusing on the commercialization of over-the-counter (“OTC”) and consumer products for men’s and women’s health, vitality and respiratory diseases, announced today, the closing of its previously announced $3 million private financing from institutional investors. “Our ability to attract high caliber institutional investors into the Company

    Read more
  • 12:56 PM

    Company on Track to Be Being Cash Flow Positive Exiting 2016 SAN DIEGO, CA–INNV, (Marketwired – Jun 15, 2016) – Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) www.innovuspharma.com (OTCQB: INNV), a company focusing on the commercialization of over-the-counter (“OTC”) and consumer products for men’s and women’s health, vitality and respiratory diseases, announced today that the Company has reduced its debt obligation by $1.5 million and also eliminated approximately $300k in derivative liabilities as of 3/31/16, resulting in a total

    Read more
  • 4:06 PM

    Innovus Pharma’s Aggregate Annual Revenues Expected to Triple to Close to $4.0 Million SAN DIEGO, CA–INNV, (Marketwired – Mar 1, 2016) – Innovus Pharmaceuticals, Inc., (“Innovus Pharma” or the “Company) www.innovuspharma.com (OTCQB: INNV) a company focusing on the commercialization of over-the-counter (“OTC”) and consumer products for men’s and women’s health, vitality and respiratory diseases, announced today the closing of the acquisition for substantially all of the assets of Beyond Human, for a cash purchase price of $630,000. In order to

    Read more
Public Wire Banner